CHMP recommends Artesunate Amivas for the initial treatment of severe malaria – Amivas
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Artesunate Amivas, intended for… read more.